Answers are grounded in this paper and cite their sources.
Evaluates ligands' effects on gene expression in Alzheimer's mouse models, indicating potential for therapy.
resulted in brain exposure sufficient to alter gene expression and reduce IL-1β levels as pharmacodynamic markers of microglial activation and neuroinflammation in an amyloidosis mouse model of Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Jesudason et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: